Variable | Quartile 1 (≤10.96) n = 18 | Quartile 2 (10.97–12.71) n = 18 | Quartile 3 (12.72–14.24) n = 18 | Quartile 4 (>14.24) n = 18 | P-value |
---|---|---|---|---|---|
Age (years), mean ± SD | 64.8 ± 10.2 | 60.1 ± 12.5 | 64.6 ± 10.3 | 69.4 ± 9.4 | 0.090 |
Male, n (%) | 11 (61.1) | 12 (66.7) | 9 (50.0) | 13 (72.2) | 0.557 |
Hypertension, n (%) | 10 (55.6) | 12 (66.7) | 12 (66.7) | 14 (77.8) | 0.572 |
Diabetes mellitus, n (%) | 5 (27.8) | 9 (50.0) | 4 (22.2) | 5 (27.8) | 0.287 |
Coronary heart disease, n (%) | 3 (16.7) | 7 (38.9) | 7 (38.9) | 4 (22.2) | 0.330 |
Atrial fibrillation, n (%) | 7 (38.9) | 6 (33.3) | 5 (27.8) | 6 (33.3) | 0.919 |
Previous history of cerebrovascular disease, n (%) | 3 (16.7) | 3 (16.7) | 0 (0.0) | 4 (22.2) | 0.243 |
Current smoker, n (%) | 8 (44.4) | 12 (66.7) | 5 (27.8) | 9 (50.0) | 0.134 |
NIHSS score at admission, median (IQR) | 9.5 (7.8–14.8) | 13 (9.0–16.3) | 18 (8.5–21.3) | 16.5 (13.8–20.0) | 0.070 |
Glucose level at admission (mg/dL), mean ± SD | 149.0 ± 78.1 | 184.3 ± 141.3 | 138.4 ± 37.2 | 137.4 ± 33.7 | 0.309 |
SBP level at admission (mmHg), mean ± SD | 143.4 ± 23.9 | 156.7 ± 17.3 | 158.7 ± 27.0 | 156.4 ± 23.4 | 0.189 |
DBP level at admission (mmHg), mean ± SD | 81.9 ± 15.1 | 87.3 ± 11.1 | 82.7 ± 12.9 | 88.8 ± 14.0 | 0.335 |
LDL-C at admission (mg/dL), median (IQR) | 43.5 (33.9–56.4) | 49.0 (36.2–56.0) | 36.8 (30.3–3.56.7) | 46.2 (41.5–56.4) | 0.384 |
TOAST type, n (%) | |||||
Large artery atherosclerosis | 9 (50.0) | 11 (61.1) | 12 (66.7) | 12 (66.7) | 0.442 |
Cardioembolism | 6 (33.3) | 6 (33.3) | 5 (27.8) | 6 (33.3) | 0.377 |
Clear reason | 3 (16.7) | 0 (0.0) | 1 (5.6) | 0 (0.0) | |
Unknown reason | 0 (0.0) | 1 (5.6) | 0 (0.0) | 0 (0.0) | |
ASPECTS at admission, median (IQR) | 7.8 (8–9) | 8 (8–9) | 7 (7–8.3) | 7 (6–7.3) | < 0.001a |
Vascular lesion | |||||
M1 of the middle cerebral artery | 14 (77.8) | 16 (88.9) | 10 (55.6) | 11 (61.1) | 0.106 |
Internal carotid artery | 4 (22.2) | 2 (11.1) | 8 (44.4) | 7 (38.9) | |
Type of anesthesia | |||||
Conscious sedation, n (%) | 17 (94.4) | 14 (77.8) | 16 (88.9) | 16 (88.9) | 0.491 |
General anesthesia, n (%) | 1 (5.6) | 4 (22.2) | 2 (11.1) | 2 (11.1) | |
Time from stroke onset to groin puncture (min), mean ± SD | 284.6 ± 60.7 | 300.1 ± 75.8 | 308.7 ± 84.6 | 268.7 ± 97.4 | 0.467 |
Type of endovascular treatment | |||||
Combined intravenous thrombolysis and thrombectomy, n (%) | 4 (22.2) | 7 (38.9) | 4 (22.2) | 4 (22.2) | 0.777 |
Intra-arterial thrombolysis alone, n (%) | 4 (22.2) | 2 (11.1) | 2 (11.1) | 2 (11.1) | |
Direct mechanical thrombectomy, n (%) | 10 (55.6) | 9 (50.0) | 12 (66.7) | 12 (66.7) | |
Frequency of mechanical thrombectomy, median (IQR) | 1.5 (0–3) | 1.5 (1–2.3) | 2 (1.8–3) | 2.5 (2–3.3) | 0.038a |
Rates of successful recanalization, n (%) | 18 (100.0) | 17 (94.4) | 14 (77.8) | 13 (72.2) | 0.048a |
Intracranial haemorrhagic transformation, n (%) | |||||
HI1 | 1 (5.6) | 1 (5.6) | 1 (5.6) | 2 (11.1) | 0.731 |
HI2 | 2 (11.1) | 0 (0.0) | 1 (5.6) | 2 (11.1) | |
PH1 | 0 (0.0) | 0 (0.0) | 1 (5.6) | 1 (5.6) | |
PH2 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (5.6) |